261G000236 - NATALIzumab INJ 20MG/ML AMP 15 ML
TED · 307825-2026Award noticeawardedNo deadline given
Value
Estimated€452,490 · 452,490 EUR
Awarded€452,490 · 452,490 EUR
WinnerBIOGEN PORTUGAL- SOC.FARMAC., LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 22 | — | 2026-08-04 |
| GILEAD SCIENCES, LDA | 18 | — | 2026-07-28 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 15 | €1,569,649 | 2026-08-04 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-04 |
| JANSSEN-CILAG FARMACEUTICA LDA | 9 | €371,730 | 2026-08-04 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33652000 Medical equipment & pharmaceuticalsDescription
NATALIzumab INJ 20MG/ML AMP 15 ML
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-12 | 2025/1303 - NATALIZUMAB [20 MG/ML 15 ML FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-07-07 | 2025/1303 - ISATUXIMAB [20 MG/ML 25 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-06-09 | 2025/1746 -EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-07-21 | 261G000791 - BINIMEtinib 45 MG COMP | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-06-09 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,7 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-05-05 | 261G000469 - INFLIximab 100 MG INJ BIOSSIMILAR (ZESSLY) | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |